NEWM&A

GNI Group (2160) to Acquire Ayumi Pharmaceutical for ¥44.8 Billion

Published on 6/7/2026

#2160#M&A#Pharma
GNI Group (2160) to Acquire Ayumi Pharmaceutical for ¥44.8 Billion

AI Summary

GNI Group (2160) has announced its intention to acquire Ayumi Pharmaceutical for a total of ¥44.8 billion. This acquisition is significant as it expands GNI's portfolio in the pharmaceutical sector. The deal is expected to enhance GNI's capabilities in drug development and potential market reach. Investors will be watching how this strategic move impacts GNI's revenue and operational synergies moving forward.

Source: Read original article (opens in new tab)

Related News

Trader Joe's (TJ) $7.4M settlement claims deadline June 9, 2026
M&A

Trader Joe's (TJ) $7.4M settlement claims deadline June 9, 2026

Jun 7

GameStop (GME) Ryan Cohen Discusses eBay Potential Opportunity
M&A

GameStop (GME) Ryan Cohen Discusses eBay Potential Opportunity

Jun 7

Intesa (ISP) Targets BPM’s €50bn Merger with Monte dei Paschi Bid
M&A

Intesa (ISP) Targets BPM’s €50bn Merger with Monte dei Paschi Bid

Jun 7

WWE (WWE) Shareholder Lawsuit Trial Canceled Amid Merger Litigation
M&A

WWE (WWE) Shareholder Lawsuit Trial Canceled Amid Merger Litigation

Jun 7